Anti-PLGF antibody
US7875704B2 · kind B2 · utility
4Cited by
3References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 24, 2006 |
| Grant date | Jan 25, 2011 |
| Priority date | — |
| Expiry date | Apr 10, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel monoclonal antibodies directed to PlGF and fragments and derivatives thereof, more particularly to humanized antibodies and fragments thereof for use in the treatment and/or prevention of pathological angiogenesis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.